Efficacy of Diabetes Nurse Expert Team Program to Improve Nursing Confidence and Expertise in Caring for Hospitalized Patients With Diabetes Mellitus

被引:15
|
作者
Corl, Dawn E. [1 ]
McCliment, Sean [2 ]
Thompson, Rachel E. [3 ,4 ]
Suhr, Louise D. [5 ]
Wisse, Brent E. [6 ,7 ]
机构
[1] Harborview Med Ctr, Seattle, WA 98104 USA
[2] Sea Mar Community Hlth Ctr, Olympia, WA 98502 USA
[3] Univ Washington, Gen Internal Med, Seattle, WA 98195 USA
[4] Harborview Med Ctr, Med Operat Consult Clin, Seattle, WA 98104 USA
[5] Harborview Med Ctr, Patient Care Serv Endocrinol, Seattle, WA 98104 USA
[6] Harborview Med Ctr, Inpatient Glycem Team, Seattle, WA 98104 USA
[7] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
关键词
D O I
10.1097/NND.0000000000000068
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Nursing care for hospitalized patients with diabetes has become more complex as evidence accumulates that inpatient glycemic control improves outcomes. Previous studies have highlighted challenges for educators in providing inpatient diabetes education to nurses. In this article, the authors show that a unit-based diabetes nurse expert team model, developed and led by a diabetes clinical nurse specialist, effectively increased nurses' confidence and expertise in inpatient diabetes care. Adapting this model in other institutions may be a cost-effective way to improve inpatient diabetes care and safety as well as promote professional growth of staff nurses.
引用
收藏
页码:134 / 142
页数:9
相关论文
共 40 条
  • [31] Changes in inflammatory markers and efficacy analysis of continuous subcutaneous insulin infusion in senior patients with type 2 diabetes mellitus hospitalized with community-acquired pneumonia: a randomized controlled trial
    Ding, Huan-Fa
    Li, Fen
    Xu, Yu-Xia
    Wang, Fang
    Ding, Zhao-Yong
    EUROPEAN GERIATRIC MEDICINE, 2024, 15 (02) : 519 - 525
  • [32] Changes in inflammatory markers and efficacy analysis of continuous subcutaneous insulin infusion in senior patients with type 2 diabetes mellitus hospitalized with community-acquired pneumonia: a randomized controlled trial
    Huan-Fa Ding
    Fen Li
    Yu-Xia Xu
    Fang Wang
    Zhao-Yong Ding
    European Geriatric Medicine, 2024, 15 : 519 - 525
  • [33] Assessment of a group-based comprehensive diabetes management program to improve glycemic control, quality of life and self-care behavior in patients with type 2 diabetes mellitus in a primary healthcare setting of a metropolitan city in India: CDMP MUM Trial
    Baviskar, Mandar Padmakar
    Rangari, Sumitra
    Mishra, Sandeep
    Mohanta, Biswendu Sundar
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2021, 41 (01) : 156 - 163
  • [34] Assessment of a group-based comprehensive diabetes management program to improve glycemic control, quality of life and self-care behavior in patients with type 2 diabetes mellitus in a primary healthcare setting of a metropolitan city in India: CDMP MUM Trial
    Mandar Padmakar Baviskar
    Sumitra Rangari
    Sandeep Mishra
    Biswendu Sundar Mohanta
    International Journal of Diabetes in Developing Countries, 2021, 41 : 156 - 163
  • [35] Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Giugliano, Robert P.
    Cannon, Christopher P.
    Blazing, Michael A.
    Nicolau, Jose C.
    Corbalan, Ramon
    Spinar, Jindrich
    Park, Jeong-Gun
    White, Jennifer A.
    Bohula, Erin A.
    Braunwald, Eugene
    CIRCULATION, 2018, 137 (15) : 1571 - +
  • [36] Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus
    Goday, A.
    Bellido, D.
    Sajoux, I.
    Crujeiras, A. B.
    Burguera, B.
    Garcia-Luna, P. P.
    Oleaga, A.
    Moreno, B.
    Casanueva, F. F.
    NUTRITION & DIABETES, 2016, 6 : e230 - e230
  • [37] Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus
    A Goday
    D Bellido
    I Sajoux
    A B Crujeiras
    B Burguera
    P P García-Luna
    A Oleaga
    B Moreno
    F F Casanueva
    Nutrition & Diabetes, 2016, 6 : e230 - e230
  • [38] Letter by Koh Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)"
    Koh, Kwang Kon
    CIRCULATION, 2018, 138 (17) : 1914 - 1915
  • [39] Letter by Donzelli et al Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)"
    Donzelli, Alberto
    Schivalocchi, Alessandro
    Giudicatti, Giulia
    CIRCULATION, 2018, 138 (17) : 1912 - 1913
  • [40] Therapy with biphasic insulin aspart 30/70 (NovoMix 30) improves glycemic control in patients with type 2 diabetes mellitus: results from a Russian cohort of IMPROVE observational program designed to study safety and efficiency of biphasic insulin aspart 30 in routine clinical practice
    Shestakova, M. V.
    Akil, Ballan
    DIABETES MELLITUS, 2010, 13 (01): : 92 - 100